Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ANIK Stock Forecast, Price Targets, Chart, Dividends & Analysis

Anika Therapeutics Inc. logo

Anika Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

25.28
 
USD
  
0.26
  
(1.04%)
Previous close: 25.02  Open: 24.99  Bid: 10.24  Ask: 40.54
52 week range    
17.88   
   29.12
Mkt Cap: 359 M  Avg Vol (90 Days): 49,118
Peers   
MDT / 
DYNT / 
SYK / 
JNJ / 
HALO / 
Last updated: Friday 4th October 2024

Stock Rankings

58
MarketXLS Rank
60
Value
61
Technical
55
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

DYNT

0 B00.135075

HALO

7 B21.560.43

JNJ

0.0307390 B24.94160.5

MDT

0.0313115 B29.487.77

STAA

2 B109.9934.16

SYK

0.0089136 B39.93351.61
Financials

ANIK Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-2 M-1 M-1 M-1000000.0-1000000.08 M91 M82 M75 M8 M
Basic EPS from continuing operations1.93-1.690.29-1.02-5.64
Basic EPS total2.612.062.222.181.31.93-1.690.29-1.02-5.64
Basic weighted shares outstanding15 M15 M15 M15 M14 M14 M14 M14 M15 M15 M
Cost of sales-21 M-21 M-24 M-27 M-31 M29 M61 M65 M63 M64 M
Depreciation-3 M-3 M-3 M-3 M-5 M5 M6 M7 M7 M6 M
DepreciationAndAmortization-3 M-3 M-3 M-3 M-5 M5 M6 M7 M7 M6 M
Diluted EPS total2.512.012.152.111.271.89-1.690.28-1.02-5.64
Diluted normalized net income/share1.89-1.690.28-1.02-5.64
Diluted weighted shares outstanding15 M15 M15 M15 M15 M14 M14 M15 M15 M15 M
GeneralAndAdministrativeExpense-1 M-1 M-1 M-2 M-2 M35 M60 M74 M85 M96 M
Gross operating profit85 M72 M79 M86 M74 M86 M69 M83 M94 M103 M
ImpairmentOfCapitalAssets389000.043 M62 M
Income before tax62 M48 M51 M46 M23 M36 M-29 M2 M-19 M-85 M
Income restructuring and M&A-7 M23 M
Income taxes23 M17 M18 M14 M4 M9 M-5 M-2 M-4 M-3 M
Interest income58000.0120000.0263000.0473000.01 M2 M-302000.0-188000.0654000.02 M
InterestExpenseNonOperating25000.019000.011000.0
MiscOtherSpecialCharges900000.0
Net income from total operations38 M31 M33 M32 M19 M27 M-24 M4 M-15 M-83 M
NetIncomeCommonStockholders38 M31 M33 M32 M19 M27 M-24 M4 M-15 M-83 M
NetIncomeContinuousOperations38 M31 M33 M32 M19 M27 M-24 M4 M-15 M-83 M
NetIncomeDiscontinuousOperations10 M
NetNonOperatingInterestIncomeExpense58000.0120000.0263000.0473000.01 M2 M-302000.0-188000.0654000.02 M
Operating income61 M48 M51 M46 M22 M34 M-28 M3 M-19 M-88 M
Operating income before depreciation (EBITDA)66 M52 M55 M50 M29 M43 M-1 M-4 M-5 M-11 M
OperatingExpense23 M24 M29 M40 M53 M52 M83 M101 M113 M129 M
Other income net-377000.0-3000.0-16000.0-906000.0-360000.0-158 M-29 M-21 M-180000.0-62 M
OtherGandA-1 M-1 M-1 M-2 M-2 M35 M60 M74 M85 M96 M
OtherImpairmentOfCapitalAssets-697000.0
OtherOperatingExpenses-38000.0-52000.0-2 M-57000.02 M3 M3 M
OtherWriteOff-377000.0-3000.0-16000.0-6000.0-360000.0-505000.0-86000.0-92000.0-180000.0-318000.0
ProvisionForGainLossOnDisposal10 M
RentAndLandingFees-1 M-1 M-1 M-2 M-2 M
Research & development expense8 M9 M11 M19 M18 M17 M23 M27 M28 M33 M
ResearchExpense8 M9 M11 M19 M18 M17 M23 M27 M28 M33 M
RestructringAndMnAIncome-7 M23 M
Revenue per share-2 M-1 M-1 M-1000000.0-1000000.08 M91 M83 M75 M8 M
SalariesAndWages-3 M-2 M-3 M-6 M-11 M-100000.0-200000.0-100000.0-1 M-3 M
Selling Gen & administrative expense15 M15 M18 M22 M34 M35 M60 M74 M85 M96 M
SellingAndMarketingExpense15 M15 M18 M22 M34 M
SellingExpense15 M15 M18 M22 M34 M
Special income/charges7 M-43 M-62 M
Total Income available for interest expense (EBIT)62 M48 M51 M46 M23 M36 M-14 M-18 M-19 M-25 M
Total common shares outstanding15 M14 M15 M15 M14 M14 M14 M14 M15 M15 M
Total net income38 M31 M33 M32 M19 M27 M-24 M4 M-15 M-83 M
Total ordinary shares15 M15 M15 M15 M15 M15 M15 M15 M15 M15 M
Total revenues106 M93 M103 M113 M106 M115 M130 M148 M156 M167 M
TotalExpenses2 M3 M5 M13 M21 M80 M145 M166 M176 M192 M
TotalRevenue75 M88 M103 M113 M106 M115 M130 M148 M156 M167 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University